Barely Significant
← all excerpts

Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.

Clin Infect Dis · 2023 · PMC10249992 · PMID 36804834

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

showed a trendP = .05actually significant
Higher TTP at baseline, an indication of lower baseline disease burden, showed a trend to lower incidence of unfavorable outcomes ( P = .05).

also in 33,481 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.